Form 4 for FENC FENNEC PHARMACEUTICALS INC.
Accepted 2026-06-01 16:05:07 ET · period of report 2026-05-31 · accession 0001926254-26-000008 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-01 16:05 | 2026-05-31 | FENC | Hackman Jeffrey S. | CEO, Dir | A - Grant | $0.00 | +1,159 | 62.8K | +2% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Shares | 2026-05-31 | A | A | 1,159 | $0.00 | 62,825 | D | — | — | (F1) Represents shares released from restriction from shares awarded 3/28/2025. |